Half Yearly Results Results Snapshot
Figures in Rs cr
Standalone Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2024 is 31.16% vs 29.48% in Sep 2023
Standalone Net Profit
Growth in half year ended Sep 2024 is -74.92% vs 101.50% in Sep 2023
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2024 is -24.49% vs 74.70% in Sep 2023
Interest
Growth in half year ended Sep 2024 is -30.77% vs 85.71% in Sep 2023
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2024 has fallen from Sep 2023
Compare Half Yearly Results Of Astrazeneca Phar With
Figures in Rs cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
795.52
4,933.00
-4,137.48
-83.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
795.52
4,933.00
-4,137.48
-83.87%
Raw Material Cost
123.00
386.36
-263.36
-68.16%
Purchase of Finished goods
492.20
988.27
-496.07
-50.20%
(Increase) / Decrease In Stocks
-158.83
15.23
-174.06
-1,142.88%
Employee Cost
129.00
1,047.96
-918.96
-87.69%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
40.11
0.00
40.11
Other Expenses
79.43
1,170.95
-1,091.52
-93.22%
Total Expenditure (Excl Depreciation)
704.91
3,608.77
-2,903.86
-80.47%
Operating Profit (PBDIT) excl Other Income
90.61
1,324.23
-1,233.62
-93.16%
Other Income
16.50
200.59
-184.09
-91.77%
Operating Profit (PBDIT)
107.11
1,524.82
-1,417.71
-92.98%
Interest
0.45
8.18
-7.73
-94.50%
Exceptional Items
-57.56
61.23
-118.79
-194.01%
Gross Profit (PBDT)
49.10
1,516.64
-1,467.54
-96.76%
Depreciation
13.23
168.82
-155.59
-92.16%
Profit Before Tax
35.87
1,347.82
-1,311.95
-97.34%
Tax
9.23
261.13
-251.90
-96.47%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
26.64
1,086.69
-1,060.05
-97.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
26.64
1,147.92
-1,121.28
-97.68%
Equity Capital
5.00
40.06
-35.06
-87.52%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
10.66
28.66
-18.00
-62.81%
Diluted Earnings per share
10.85
28.61
-17.76
-62.08%
Operating Profit Margin (Excl OI)
11.39%
26.84%
0.00
-15.45%
Gross Profit Margin
6.17%
30.74%
0.00
-24.57%
PAT Margin
3.35%
22.03%
0.00
-18.68%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 795.52 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 31.16% vs 29.48% in Sep 2023
Half Yearly - Standalone Net Profit
Standalone Net Profit 26.64 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is -74.92% vs 101.50% in Sep 2023
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 90.61 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is -24.49% vs 74.70% in Sep 2023
Half Yearly - Interest
Interest 0.45 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is -30.77% vs 85.71% in Sep 2023
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.39%
in Sep 2024Figures in Rs %
Growth in half year ended Sep 2024 has fallen from Sep 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
